Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nateglinide vs Acarbose for Post-Prandial Glucose in Type 2 Diabetics on Insulin Glargine
NCT00437918Phase 4Completed
- Sponsor
- Inje University
- Start
- Jan 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nateglinide, acarbose in type 2 diabetes mellitus (T2DM), sponsored by Inje University. Started Jan 2007; status: completed.
02
Drugs
nateglinideacarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00437918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437918.